No abstract available
MeSH terms
-
Ado-Trastuzumab Emtansine
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents / adverse effects*
-
Breast Neoplasms / drug therapy*
-
Clinical Trials, Phase III as Topic
-
Female
-
Hemorrhage / chemically induced*
-
Humans
-
Maytansine / adverse effects
-
Maytansine / analogs & derivatives*
-
Telangiectasis / chemically induced*
-
Trastuzumab
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Maytansine
-
Trastuzumab
-
Ado-Trastuzumab Emtansine